In light of the adverse prognosis related to severe mitral regurgitation, heart failure, or
sudden cardiac death in a subset of patients with mitral valve prolapse (MVP), identifying …

Valvular heart disease is a leading cause of cardiovascular morbidity and mortality and a
major contributor of symptoms and functional disability. Knowledge of valvular heart disease …

Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in
patients with MVP, involving two phases based on the clinical and imaging context and the …

Background Mitral annular disjunction is the atrial displacement of the mural mitral valve
leaflet hinge point within the atrioventricular junction. Said to be associated with malignant …

Background Patients with mitral valve prolapse (MVP) may develop adverse outcomes even
in the absence of mitral regurgitation or left ventricular (LV) dysfunction. Purpose To …

Background The dynamic consequences of mitral annular disjunction (MAD) on the mitral
apparatus and the left ventricle remain unclear and are crucial in the context of mitral …

Mitral valve prolapse (MVP) is the most frequent valve condition but remains a conundrum in
many aspects, particularly in regard to the existence and frequency of an arrhythmic form …

Mitral valve prolapse (MVP) is the most common valve disease in the western world and
recently emerged as a possible substrate for sudden cardiac death (SCD). It is estimated an …

Aims Arrhythmic mitral valve syndrome is linked to life-threatening ventricular arrhythmias.
The incidence, morphology and methods for risk stratification are not well known. This …

Background Idiopathic ventricular fibrillation (IVF) is diagnosed in patients with ventricular
fibrillation of which the origin is not identified after extensive evaluations. Recent studies …